Replies to post #712530 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

First off, you might restart your analysis with the fact that commercially approved products sold to the public would not constitute a prerevenue company.

ooh thats right. That is why Outlook Therapeutics is now worth 175 billion because EMA and the MHRA approved LYTENAVA

Ooh darn I often mix up the M with the B

[StonkMaster]

Sure, you got me.

Regardless, I don't think NWBO is a $50 (60B MC) company after MAA approval and MTD dismissal, which is what we were originally discussing.

So, if your argument is that NWBO could potentially one day be worth 60B dollars if all goes well... sure, that's great.

[space~farm]

Absolutely, but revenue and profit are very different in cell therapy and that is why every major player has established a partnership or acquisition.